Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Femara receives E.U. approval as first-line breast cancer therapy

Feb. 1, 2001

Preparation and antitumor activity of new xanthone compound from Asta Medica

Feb. 1, 2001

MTC-DOX assigned orphan drug status for liver cancer Rx by FDA

Feb. 1, 2001

Nastech begins phase I trial of intranasal interferon alfa

Jan. 31, 2001

Caelyx receives approval in Canada for treatment of advanced ovarian cancer

Jan. 31, 2001

Kosan receives NCI grant to improve epothilone production

Jan. 31, 2001

Merck reports synthesis, use of new peptidomimetic protein prenyltransferase inhibitors

Jan. 30, 2001

Inhibitors of JNK, compositions and methods of use described by Vertex team

Jan. 30, 2001

New heterocyclic chemopreventive agents described in U.S. patent

Jan. 30, 2001

Cel-Sci/NCI CRADA renewed and expanded

Jan. 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...